| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 284.00K | — |
| Operating expense | — | — |
| Net income | -127.12M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, VRDN returned +26.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -21.9% |
| 1 year | +26.3% |
| 5 years | +81.5% |
| 10 years | -77.0% |
| All-time high | $1,586.25 (Jun 2014) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in VRDN would be worth today ›No. Viridian Therapeutics, Inc. has not paid a dividend in the past 12 months.
Viridian Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol VRDN.
Viridian Therapeutics, Inc. is part of the Healthcare sector.
Viridian Therapeutics, Inc. has a market cap of 2.75B USD, based on the latest quote.
Viridian Therapeutics, Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.